Shekher Mohan
Baptist College of Health Sciences, National Institutes of Health, Oklahoma State University Center for Health Sciences, University of Hertfordshire, Liberty University
About
Shekher Mohan, Ph.D., is Associate Dean for Research & Sponsored Programs and Associate Professor of Pharmacology at Baptist Health Sciences University, College of Osteopathic Medicine (BUCOM), serving as the catalyst for BUCOM’s research strategy, policy, and compliance. He earned a Ph.D. in Biomedical Science (Pharmacology) from Oklahoma State Univ., Center for Health Sciences and a B.Sc. (Hons) in Life Sciences (Pharmacology) from the Univ., of Hertfordshire, England, UK. Dr. Mohan has led NIH-funded initiatives and authored 20+ peer‑reviewed papers in neuroscience, neurology, and behavioral science. Since 2018, he has held roles a number of leadership roles, including his current role as Associate Dean for Research and Scholarly Activity (2024-present), Director of Sponsored Programs (2024-2025), and Acting IRB Administrator (2024-2025) and Director of the Research Internship Program (2017-2020). He also served as a National Institutes of Health (NIH) as Scientific Review Officer (SRO), and currently serves as National Faculty as a National Board of Osteopathic Medical Examiners (NBOME) item writer/reviewer, and member of the Americal College of Clinical Pharmacy (ACCP) Educational Committee.
Employment
-
Baptist College of Health Sciences Associate Professor2023 - Present
-
National Institutes of Health SRO2023 - 2023
-
Liberty University Associate Professor2020 - 2023
-
Manchester University Assistant Professor2017 - 2020
-
Marshall University Assistant Professor2014 - 2017
Education
-
Oklahoma State University Center for Health Sciences Ph.D.2004 - 2008
-
University of Hertfordshire Bs.C (HONS) Pharmacology1998 - 2002
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS) Save
- Genetic Deletion of PGF2α-FP Receptor Exacerbates Brain Injury Following Experimental Intracerebral Hemorrhage. Save
- Gender Differences in Withdrawing Infants. Save
- Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity. Save
- Role of vasopressin and its antagonism in stroke related edema. Save
- Contribution of PGE2 EP1 receptor in hemin-induced neurotoxicity. Save
- Putative role of prostaglandin receptor in intracerebral hemorrhage. Save
- Evaluation of leukemia inhibitory factor (LIF) in a rat model of postoperative pain. Save
- Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk. Save
- Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells. Save